Regina M. Ondrasik, DO

PGY-3

Professional education

  • 2019, DO, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania
  • 2015, MS, Biomedical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania
  • 2011, BS, Biology, Saint Joseph's University, Philadelphia, Pennsylvania

Presentations

  • Ondrasik RM, Cook LJ, Siegel CA, Tsongalis GJ, Khan WA. Validation of a rapid HLA-DQA1*05 pharmacogenomics assay to identify at-risk resistance to anti-TNF therapy in inflammatory bowel disease (IBD) patients. Poster presentation at Association for Molecular Pathology (AMP) Annual Meeting, Philadelphia, PA, November 2021.
  • Ondrasik RM, Creed C, Anderson SR, Green DC, Houde BE, Godwin KN, Vaickus LJ, Lefferts JA, Khan WA, Tsongalis GJ. Validation of a rapid PCR-based assay for BRAF V600 status for prognostication and therapeutic selection in colorectal cancer patients. Poster presentation at Association for Molecular Pathology (AMP) Annual Meeting, Philadelphia, PA, November 2021.
  • Ondrasik RM, Deharvengt S, Green DC, Winnick KN, Hughes EG, Huang G, Zanazzi G. Identification of Novel Genomic Alterations in Pineal Parenchymal Tumors (#ST46). Poster presentation at Association for Molecular Pathology (AMP) Annual Meeting, Virtual, November 2020.
  • Ondrasik R, O’Hern K, Chambers M, Jackson C, Hughes E, Lefferts J, Tsongalis G, Sriharan A. Artificial Intelligence and Novel Molecular Diagnostics in the Prognostication of Advanced Melanoma (#314). American Society of Dermatopathology (ASDP) Annual Meeting, Virtual, November 2020.
  • Ondrasik R, Gvozdjan K. Isolated Central Nervous System Relapse of Acute Myeloid Leukemia in a Patient with Worsening Chronic Graft-Versus-Host Disease, Poster, College of American Pathologists (CAP) Annual Meeting, Orlando, Florida, September 23, 2019

Publications

  • Ondrasik, RM, Jordan, P, Sriharan, A. A clinical mimicker of melanoma with distinctive histopathology: Topical silver nitrate exposure. J Cutan Pathol. 2020; 47( 12): 1205– 1210.
  • Barth BM, Wang W, Toran PT, Fox TE, Annageldiyev C, Ondrasik RM, Keasey NR, Brown TJ, Devine VG, Sullivan EC, Cote AL, Papakotsi V, Tan SF, Shanmugavelandy SS, Deering TG, Needle DB, Stern ST, Zhu J, Liao J, Viny AD, Feith DJ, Levine RL, Wang HG, Loughran TP Jr, Sharma A, Kester M, Claxton DF. Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia. Blood Adv. 2019 Sep 10;3(17):2598-2603. doi: 10.1182/bloodadvances.2018021295.

Professional interests

  • Blood banking and transfusion medicine
  • Cellular therapy
  • Apheresis
  • Laboratory administration
  • Pathology teaching
  • Laboratory medicine advocacy

Why I enjoy the pathology program at Dartmouth Hitchcock Medical Center

I really appreciate the program’s collaborative environment. I felt welcomed as part of the team since day 1. The residents are all supportive of each other, and the faculty are very approachable. There are many research opportunities and useful didactics and conferences. There is a good variety of interesting cases and opportunities to interact with other specialties in tumor board and M&M. The program is strong in both AP and CP, so this is a great place for a well-rounded training as well as to focus on any particular interests. Also, our program director and coordinator are awesome. In addition, there are many outdoor activities in the Upper Valley.

About me

Regina loves nature and the outdoors, especially hiking, mountain biking, snowboarding, camping, and beach trips. She also likes cooking and movies. Most of all, she enjoys spending time with family and friends.